Clinical Report: Framingham Risk Score Predicts Both Heart Failure and Cancer

Overview

The Framingham risk score (FRS), traditionally used to estimate 10-year coronary heart disease risk, is associated with incident heart failure and new-onset cancer. Analysis of large cohorts demonstrated that individuals with higher FRS have significantly increased risks for both conditions, suggesting the score reflects broader global vulnerability beyond cardiovascular disease.

Background

The FRS integrates classical cardiovascular risk factors such as age, sex, blood pressure, lipid levels, diabetes, and smoking status to predict coronary heart disease events. It has also been validated for other cardiovascular diseases including stroke and heart failure. Recent evidence indicates that cardiovascular disease and cancer share common risk factors and pathogenic pathways, including inflammation and environmental determinants. This interplay has led to the emerging field of bidirectional cardio-oncology, which explores the complex relationship between cardiovascular health and cancer.

Data Highlights

Key Findings

• The FRS predicts not only heart failure but also incident cancer, a novel association.
• Individuals in the highest FRS tertile have over twice the risk of developing cancer and up to ten times the risk of heart failure.
• These associations remain significant after adjusting for renal function, urinary albumin excretion, and competing mortality risks.
• Findings were validated across two large, independent population cohorts, enhancing reproducibility.
• Shared risk factors and pathogenic mechanisms, such as inflammation, likely underlie the link between cardiovascular disease and cancer.
• The FRS may serve as a broader metric of global vulnerability beyond cardiovascular risk alone.

Clinical Implications

Clinicians should consider the FRS as a tool for integrated risk assessment encompassing both cardiovascular disease and cancer. Patients with high FRS scores may benefit from intensified cardiovascular risk management alongside proactive cancer prevention strategies, including lifestyle modification and appropriate screening. The FRS's routine availability in primary care settings facilitates early identification of individuals at elevated lifetime risk for both conditions.

Conclusion

The Framingham risk score extends beyond cardiovascular risk prediction to capture susceptibility to cancer, supporting a paradigm shift toward integrated lifelong prevention of multiple chronic diseases. This underscores the importance of comprehensive risk assessment and coordinated preventive strategies in clinical practice.

References

1. van den Berg PF et al. 2023 -- Framingham risk score associates with incident cancer and heart failure